Comparative Clinical Study of Warfarin and Rivaroxaban (Newer Anti-Coagulant) with Respect to Efficacy and Side Effects in the Treatment of Peripheral Venous Thromboembolism

Thrishankareddy P

Abstract: New oral anticoagulants (NOAC; rivaroxaban, dabigatran, apixaban) have become available as an alternative to warfarin anticoagulation in peripheral venous thromboembolism. We assessed the effectiveness and safety along with side effects of rivaroxaban vs warfarin in patients experiencing venous thromboembolism(both deep vein thrombosis and pulmonary embolism)

Keywords: Venous thromboembolism, Warfarin, Rivaroxaban, Bleeding

Country: India, Subject Area: Pharmaceutical Science

Pages: 222 - 232

Edition: Volume 8 Issue 11, November 2019

How to Cite this Article?

Thrishankareddy P, "Comparative Clinical Study of Warfarin and Rivaroxaban (Newer Anti-Coagulant) with Respect to Efficacy and Side Effects in the Treatment of Peripheral Venous Thromboembolism", International Journal of Science and Research (IJSR), https://www.ijsr.net/archive/v8i11/show_abstract.php?id=ART20202436, Volume 8 Issue 11, November 2019, 222 - 232

Download PDF